Evidence map›Paper›PMID 27542984›Full record

ArticleBMC plant biology2016

Ubiquitous miR159 repression of MYB33/65 in Arabidopsis rosettes is robust and is not perturbed by a wide range of stresses.

Yanjiao Li, Maria Alonso-Peral, Gigi Wong, Ming-Bo Wang, Anthony A Millar

Abstract read
In one paragraph

Article in BMC plant biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The PtDPL1Frontiers in plant science · 2025
    Article
  8. Overexpression ofGenes · 2024
    Article
  9. Article
  10. Physiology and molecular biology of plants : an international journal of functional plant biology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Sw5a gene confers resistance to ToLCNDV and triggers an HR response after direct AC4 effector recognition.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Article
  19. A Novel R2R3-MYB GeneFrontiers in plant science · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanjiao LiPlant Science Division, Research School of Biology, Australian National University, Canberra, 2601, ACT, Australia.
Maria Alonso-PeralPlant Science Division, Research School of Biology, Australian National University, Canberra, 2601, ACT, Australia.
Gigi WongPlant Science Division, Research School of Biology, Australian National University, Canberra, 2601, ACT, Australia.
Ming-Bo WangCSIRO, Agriculture, Canberra, 2601, ACT, Australia.
Anthony A MillarPlant Science Division, Research School of Biology, Australian National University, Canberra, 2601, ACT, Australia. tony.millar@anu.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe microR159 (miR159) - GAMYB pathway is conserved in higher plants, where GAMYB, expression promotes programmed cell death in seeds (aleurone) and anthers (tapetum). In cereals, restriction of GAMYB expression to seeds and anthers is mainly achieved transcriptionally, whereas in Arabidopsis this is achieved post-transcriptionally, as miR159 silences GAMYB (MYB33 and MYB65) in vegetative tissues, but not in seeds and anthers. However, we cannot rule out a role for miR159-MYB33/65 pathway in Arabidopsis vegetative tissues; a loss-of-function mir159 Arabidopsis mutant displays strong pleiotropic defects and numerous reports have documented changes in miR159 abundance during stress and hormone treatments. Hence, we have investigated the functional role of this pathway in vegetative tissues.

resultsIt was found that the miR159-MYB33/65 pathway was ubiquitously present throughout rosette development. However, miR159 appears to continuously repress MYB33/MYB65 expression to levels that have no major impact on rosette development. Inducible inhibition of miR159 resulted in MYB33/65 de-repression and associated phenotypic defects, indicating that a potential role in vegetative development is only possible through MYB33 and MYB65 if miR159 levels decrease. However, miR159 silencing of MYB33/65 appeared extremely robust; no tested abiotic stress resulted in strong miR159 repression. Consistent with this, the stress responses of an Arabidopsis mutant lacking the miR159-MYB33/65 pathway were indistinguishable from wild-type. Moreover, expression of viral silencing suppressors, either via transgenesis or viral infection, was unable to prevent miR159 repression of MYB33/65, highlighting the robustness of miR159-mediated silencing.

conclusionsDespite being ubiquitously present, molecular, genetic and physiological analysis failed to find a major functional role for the miR159-MYB33/65 pathway in Arabidopsis rosette development or stress response. Although it is likely that this pathway is important for a stress not tested here or in different plant species, our findings argue against the miR159-MYB33/65 pathway playing a major conserved role in general stress response. Finally, in light of the robustness of miR159-mediated repression of MYB33/65, it appears unlikely that low fold-level changes of miR159 abundance in response to stress would have any major physiological impact in Arabidopsis.

Indexed as

ArabidopsisArabidopsis ProteinsGene Expression Regulation, PlantMicroRNAsStress, PhysiologicalTranscription FactorsUbiquitinationArabidopsis ProteinsMicroRNAsMIRN159 microRNA, ArabidopsisMyb33 protein, ArabidopsisMyb65 protein, ArabidopsisTranscription FactorsArabidopsisGAMYB-likemiR159StressViral silencing suppressors

Identifiers

PMID27542984
PMCPMC4992245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.